The Hunt For Life Sciences' Next Big City In The U.S.

By Amber Schiada

The race is on for companies looking to scale biotech in smaller U.S. markets to grasp an early-mover advantage. As the life sciences industry continues to grow, so does the need for space. This has pushed developers to adopt innovative solutions to keep up with demand. From mixing R&D lab space and advanced manufacturing facilities in one building, having room to set up operations and grow in place is a significant draw for many startups. Becoming an early-mover is a strategy that could result in benefits such as lowering overall occupancy costs.